Cancer Research Annual Meeting 2010  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 3078-3084, July 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moesta, K. T.
Right arrow Articles by Mang, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moesta, K. T.
Right arrow Articles by Mang, T. S.

Lack of Reciprocity in Drug and Light Dose Dependence of Photodynamic Therapy of Pancreatic Adenocarcinoma in Vitro1

K. Thomas Moesta, William R. Greco, Stephen O. Nurse-Finlay, John C. Parsons and Thomas S. Mang2

Great Lakes Biomedical Laser Research Center, Department of Oral and Maxillofacial Surgery, State University of New York at Buffalo, Buffalo, New York 14214-3008 [T. S. M.]; Robert-Roessle-Clinic, Robert-Roessle-Strasse 10, O-1115 Berlin-Buch, Germany [K. T. M.]; and Departments of Radiation Biology [S. O. N-F.] and Biomathematics [W. R. G., J. C. P.] and Grace Cancer Drug Center [W. R. G.], Roswell Park Cancer Institute, New York State Department of Health, Buffalo, New York 14263-0001

Two human pancreatic cell lines, MIA PaCa 2 and Capan 2, were treated by photodynamic therapy in vitro with Photophrin (0.01–25 µg/ml; 24 h) and then light (1–50 J/cm2; {lambda} = 630 nm). The following model was fit to 6 datasets with weighted nonlinear regression: Formula where F = 1 or Formula or Formula The symbols are: E, cell growth; Econ, control growth in the absence of the combination; B, background signal; m, slope parameter; {gamma}, interaction parameter; D, concentration of Photofrin; L, light dose; F, fraction of Photofrin not photobleached by the light dose; k, k1, k2, bleaching parameters; A, distribution parameter for biexponential bleaching equation. Simple reciprocity of photosensitizer concentration and light dose was not found; compensation for photobleaching was critical. MIA PaCa2 required the monoexponential bleaching factor, whereas Capan 2 required the biexponential bleaching factor. The greater photosensitivity of MIA PaCa2 over Capan 2 can be best explained not by differences in the interaction parameter but rather by differences in the photobleaching pattern and rate. It may be possible to further enhance the selectivity of photodynamic therapy if differences in photobleaching between different cell types can be exploited by adequate dosimetry.

1 Supported by National Cancer Institute Grants CA47299, CA55791, CA46732, RR10742 and CA16056. K. T. M. received support from Deutsche Forschungsgemeinschaft (Bad Godesberg, Germany).

2 To whom requests for reprints should be addressed, at Department of Oral and Maxillofacial Surgery, 112 Squire Hall, State University of New York at Buffalo, 3435 Main Street, Buffalo, NY 14214-3008.

Received 8/ 2/94. Accepted 5/16/95.




This article has been cited by other articles:


Home page
Cancer Res.Home page
B. W. Pogue, B. Ortel, N. Chen, R. W. Redmond, and T. Hasan
A Photobiological and Photophysical-based Study of Phototoxicity of Two Chlorins
Cancer Res., January 1, 2001; 61(2): 717 - 724.
[Abstract] [Full Text]


Home page
MutagenesisHome page
K. Halkiotis, D. Yova, and G. Pantelias
In vitro evaluation of the genotoxic and clastogenic potential of photodynamic therapy
Mutagenesis, March 1, 1999; 14(2): 193 - 198.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.